Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer

ConditionsRectal Cancer Quality of Life Radiation Therapy Chemoradiation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorLudwig-Maximilians - University of Munich

About this trial

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional Outcome, oncological outcome and toxicity in patients treated with neoadjuvant short term radiation or long-term chemoradiation followed by surgery

Eligibility criteria

Qualifiers

histologically proven rectal Cancer without distant metastases

indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation

age >=18 years

written informed consent

Disqualifiers

age < 18 years

prior systemic therapy with regard to rectal Cancer

distant metastasis

second malignancy

Trial design

Treatments tested in this trial

EORTC QLQ C30
EORTC QLQ CR29

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Ludwig-Maximilians - University of Munich

Lead sponsor

Source ClinicalTrials.gov